RecallDepth
Class III Ongoing

Trandolapril and Verapamil Hydrochloride Extended-Release Tablets 2 mg / 180 mg, 100-count Bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale -Bardez, Goa 403513, India, Manufactured for Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-295-01

This recall is currently active, issued August 30, 2023. It was issued by Glenmark Pharmaceuticals Inc., Usa.

Company
Glenmark Pharmaceuticals Inc., Usa
Recall Initiated
August 14, 2023
Posted
August 30, 2023
Recall Number
D-1095-2023
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
1,200 bottles
Firm Location
Mahwah, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Subpotent: Out of Specification for Assay Test at the 3-month time point.

Distribution

nationwide in the U.S.

Lot / Code Info

Batch # 19224744

More recalls by Glenmark Pharmaceuticals Inc., Usa

View all recalls by this company →

Other recent Class III Drug recalls